BJP will win 150 seats in next Karnataka Assembly polls: Shobha

Mangaluru, May 31: The bus services by private operators in Dakshina Kannada and Udupi Districts will begin from tomorrow (June 1) with 15 per cent hike in the fares, Canara Bus Owners Association president Rajavarma Ballal said on Sunday.

In a statement issued here, he said that the members of the Association have appealed for a 3-month tax break. ''We have received tax breaks for 2 months and have demanded for an additional month again,'' he added.

He said that the government has agreed to a 15 per cent hike in bus fares. All the passes issued already will be converted into cash cards and no discounts will be available till the end of the COVID-19 crisis.

An added attraction in private buses will be the option of paying travel fares through smart cards.

According to Dakshina Kannada Bus Operators Association president Dilraj Alva, 50 per cent of 325 private city buses will resume their services on Monday. It also meant that 50 per cent of buses will operate on the allotted routes.

The smart cards (or travel cards called Chalo Card) will not be introduced on all routes at a time. They will be introduced in a phased manner covering all routes from Monday.

Mangaluru, Mar 28: After a youth from Dakshina Kannada who tested positive for the deadly Covid-19 revealed that he had travelled by a bus, authorities have requested all his fellow passengers to visit their nearest district hospital. 

The 21-year-old man hailing from Belthangady taluk had flown from Dubai to Bengaluru on March 21 and on the same day travelled to Mangaluru by the KSRTC bus bearing registration number KA 19, F3329. 

As he was suffering from fever and cough he was admitted to Puttur government hospital on March 24. He was tested positive for the novel coronavirus on March 27.   

It is not yet know how many passengers were there on board the above mentioned bus which had departed Bengaluru at 4:30 p.m. on March 21. It is believed that most of the passengers who travelled by this bus are residents of Dakshina Kannada. 

Hence, the KSRTC authorities today requested all the passengers who travelled by this bus to visit their nearest district hospital for necessary checkup. The passengers also were urged to quarantine themselves for next couple of weeks.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.